Pharmacists and clinicians share strategies to streamline training, collaboration, and patient care with BTCEs.
Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP, FASHP
Advertisement
Articles by Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP, FASHP
Experts detail the workflows and decisions behind launching complex bispecific therapies.
Multicenter data suggests dexamethasone may safely replace tocilizumab for low-grade CRS.
Don Moore, PharmD, BCPS, BCOP, DPLA, FCCP, FASHP, received a leadership award at the 2025 HOPA Annual Meeting.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Scrutiny of GLP-1 Compounding Is Just Getting Started, Expert Says
2
FDA Approves Veligrotug-vvze as First Agent With Data in Both Active and Chronic Thyroid Eye Disease
3
From Misnomer to Meaning: A Patient-Centered Shift from PCOS to PMOS
4
Menin Inhibitors in AML: Frequently Asked Questions
5